About St. Luke's Internat. Hospital, Breast Surgical Oncology
聖路加国際病院は、東京都中央区にある病院である。事業主体は、日本聖公会系列の学校法人聖路加国際大学。なお、「せいろかこくさいびょういん」は正式な読みではない。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Genentech, Inc.
1
Clinical Trials at St. Luke's Internat. Hospital, Breast Surgical Oncology
During the past decade, St. Luke's Internat. Hospital, Breast Surgical Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer
2017-07-24
2022-09-26
Completed
333
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
2020-10-09
2027-03-18
Active, not recruiting
992
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Internat. Hospital, Breast Surgical Oncology"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at St. Luke's Internat. Hospital, Breast Surgical Oncology
According to Clinical.Site data, the most researched conditions in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are
"Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials), "Triple Negative Breast Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Internat. Hospital, Breast Surgical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Internat. Hospital, Breast Surgical Oncology
Most popular intervention types in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Docetaxel" (2 trials), "Doxorubicin" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Internat. Hospital, Breast Surgical Oncology
The vast majority of trials in "St. Luke's Internat. Hospital, Breast Surgical Oncology" are
5 trials for "All" genders.
Clinical Trials Status at St. Luke's Internat. Hospital, Breast Surgical Oncology
Currently, there are NaN active trials in "St. Luke's Internat. Hospital, Breast Surgical Oncology".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in St. Luke's Internat. Hospital, Breast Surgical Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Internat. Hospital, Breast Surgical Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".